SMTL ID : 5v9p.1

Crystal structure of pyrrolidine amide inhibitor [(3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidin-1-yl][3-(propan-2-yl)-1H-pyrazol-5-yl]methanone (compound 35) in complex with KDM5A

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.00 Å
Oligo State
hetero-oligomer
Ligands
1 x NI: NICKEL (II) ION(Non-covalent)
2 x ZN: ZINC ION(Non-covalent)
1 x 90S: [(3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidin-1-yl][3-(propan-2-yl)-1H-pyrazol-5-yl]methanone(Non-covalent)
1 x SO4: SULFATE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Liang, J. et al., From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors. Bioorg. Med. Chem. Lett. (2017)
Release Date
2017-05-10
Peptides
Lysine-specific demethylase 5A: A
Lysine-specific demethylase 5A: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Lysine-specific demethylase 5A

Lysine-specific demethylase 5A

Related Entries With Identical Sequence

5ceh.1 | 5fp2.1 | 5fp2.2 | 5k4l.1 | 5k4l.2 | 5tx1.1 | 5tx1.2 | 5v9t.1 | 5v9t.2 | 6az0.1 | 6f2r.1 | 6j3y.1 | 6j3z.1 | 6pdw.1 | 6pdy.1 | 6pe0.1 | 6uqe.1 | 6z7n.1 | 7s78.1 | 7s78.2